Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

COYA

Coya Therapeutics Inc

Apr 30 • 01:15PM ET

4.21

+0.14 3.44 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ALNY ARWR IONS MDGL ARVN AKRO MRNA VRTX NBIX BMRN

| Held by: VTI VXF DFAS IWC DFMC DCOR DFAC DFSU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.20	Insider Own	14.77%	Shs Outstand	20.93M	Perf Week	-3.00%
Market Cap	98.75M	Forward P/E	-	EPS next Y	-1.14	Insider Trans	0.00%	Shs Float	19.99M	Perf Month	6.85%
Enterprise Value	51.93M	PEG	-	EPS next Q	-0.42	Inst Own	33.92%	Short Float	3.86%	Perf Quarter	-8.48%
Income	-21.23M	P/S	12.42	EPS this Y	-28.91%	Inst Trans	17.02%	Short Ratio	5.41	Perf Half Y	-36.79%
Sales	7.95M	P/B	2.05	EPS next Y	30.37%	ROA	-45.02%	Short Interest	0.77M	Perf YTD	-27.41%
Book/sh	2.06	P/C	2.11	EPS next 5Y	13.80%	ROE	-51.39%	52W High	7.75 -45.68%	Perf Year	-36.12%
Cash/sh	2.00	P/FCF	-	EPS past 3/5Y	-1.01% -75.69%	ROIC	-49.33%	52W Low	3.71 13.47%	Perf 3Y	-12.66%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	99.66%	Volatility	6.39% 6.69%	Perf 5Y	-
Dividend TTM	-	EV/Sales	6.53	EPS Y/Y TTM	-22.26%	Oper. Margin	-255.05%	ATR (14)	0.28	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.50	Sales Y/Y TTM	123.57%	Profit Margin	-267.14%	RSI (14)	45.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.50	EPS Q/Q	-56.28%	SMA20	-3.32%	Beta	0.50	Target Price	15.64
Payout	-	Debt/Eq	0.00	Sales Q/Q	202768.80%	SMA50	-5.80%	Rel Volume	0.28	Prev Close	4.07
Employees	8	LT Debt/Eq	0.00	Earnings	Mar 16 BMO	SMA200	-23.08%	Avg Volume	142.73K	Price	4.21
IPO	Dec 29, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	-24.77% 77.27%	Trades		Volume	24,212	Change	3.44%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)